Fulcrum Therapeutics的动态

Transcript

Why I choose to work in rare disease is for me the motivation that patients who historically have been hard to find have been underserved, under treated. The potential to be able to do something for these patients is for me the motivator. We have a great gift that we can bring to these patients by bringing in advancing medicines. So for me all patients, irrespective of whether they're have a condition that affects millions. Thousands or hundreds, I think all of these patients should be able to benefit from the gifts that we're able to provide. We are fulcrum and we are rare.